Loading
Latest filing published 14 Nov 2025 for COLLEGIUM PHARMACEUTICAL, INC, €367k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Vikram Karnani is a declared insider of Collegium Pharmaceutical, Inc, with filings sourced from SEC (Form 4). We count 3 filings; the first trade dates from 12 November 2024 and the latest from 10 February 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 12 February 2026: a share grant, in Collegium Pharmaceutical, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations